21/09/2026
Dear AT Community,
There was some fantastic news over the weekend: the US Food and Drug Administration (FDA) approved IntraBio’s drug AQNEURSA® (levacetylleucine) for the treatment of ataxia in children and adults diagnosed with ataxia telangiectasia (AT) in America. This is the first treatment that has been approved, ever, for AT in the world and is cause for celebration!
It has taken a long time to reach this stage and we are so grateful to IntraBio for their perseverance with this treatment, and to all the families who have taken part in the clinical trials, the medical teams and scientists around the world – you have all played a massive part in making this happen!
AQNEURSA® is not yet approved in Europe or the UK, but this announcement marks a very significant step towards this becoming a reality here too. As soon as we have more news with progress in the UK we will share this with you. In the meantime, more can be read about the treatment here: IntraBio Announces U.S. FDA Approval of AQNEURSA® (levacetylleucine) for Ataxia-Telangiectasia
https://www.businesswire.com/news/home/20260918198606/en/IntraBio-Announces-U.S.-FDA-Approval-of-AQNEURSA-levacetylleucine-for-Ataxia-Telangiectasia?fbclid=IwY2xjawUdyABwZG9mAWV4dG4DYWVtAjEwAGJyaWQRMUJndnF5V0s4c3AxUmRMb09zcnRjBmFwcF9pZBAyMjIwMzkxNzg4MjAwODkyAAEeuuorCWj-MxJLH_cXWcHo6qoUkarBWUPwFzTD8YbF6jMJF0LPgqKRCvIfCSY_aem_zyBiKdsXZy3BHAZmF-VV-A
is where it’s AT. Ataxia-Telangiectasia A-T Society A-T CureTeam Action for A-T BrAshA-T Ataxia-Telangiectasia
Best wishes
Susie Norbury
Director of Fundraising & Operations